Skip to main content

Table 1 The clinical and pathological characteristics of three male breast cancer patients

From: The clinical manifestations and treatment of male breast cancer: a report of three cases

Case Age Tumor size (mm) T N M Stage Histology Nuclear grade ER PgR HER2 Ki67 Adjuvant therapy
1 64 10 1 0 0 I Solid-tubular carcinoma 1 + + 0 Unknown Tamoxifen 20 mg
2 64 16 1 0 0 I Solid-tubular carcinoma 1 + + 0 Unknown Tamoxifen 20 mg
3 69 24 2 1 0 IIB Scirrhous carcinoma 3 + + 0 21.2 % Taxotere (75 mg/m2) and cyclophosphamide (600 mg/m2)
Tamoxifen (20 mg)
  1. T tumor, N lymph node, M metastasis